Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
← Scanner

ACRVAcrivon Therapeutics, Inc. Common Stock

Unknown·Unknown·NASDAQ·Mkt cap $0.00
$1.45
-$0.14 (-8.54%) today
IEX feed · not consolidated
Last updated Nov 13, 1:00 PM
54/100 Opportunity
61Risk
26Momentum
51Pullback
72Quality
50Valuation
60Trend
Price & History (up to 5 years)
→
Low 0.00— support · — resistanceHigh 0.00
Technical Indicators
RSI (14)46.6
MACD hist-0.01
ATR (14)0.10
SMA 201.90
SMA 501.98
SMA 2001.79
Rel volume0.4x
Boll upper2.18
Boll lower1.62
52w high3.54
52w low1.27
5y high24.15
5y low1.06
Hist. vol91%
Max drawdown-57%
Long-Term DowntrendWeak MomentumWait for ConfirmationEntry: No Setup
Decision SummaryInternal Rule-Based Analysis
Current Rating
Weak Setup
Opportunity Score
54/100
Risk Level
High
Best Action
Add to watchlist and monitor for confirmation

Why: ACRV is trading near recent levels (+1.1% today). Overall, the company is reasonably solid. The long-term trend is down, which raises the bar for any bullish setup. Short-term momentum is still weak, so confirmation is needed before acting. Risk is elevated — size carefully and require confirmation.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality72
Historical Context50
Valuation50
Trend60
Momentum26
Pullback51
News Sentiment50
Business Move50
Sector Strength59
Risk/Reward53
Entry Timing25
Sell Risk44
Risk61

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.